Atrium Therapeutics在完成5000万美元股权融资后股价大涨

路透中文
Oct 08
BUZZ-Atrium <a href="https://laohu8.com/S/LENZ">Therapeutics</a>在完成5000万美元股权融资后股价大涨

10月8日 - ** 心脏病药物开发商Atrium Therapeutics(RNA.O)周四开盘前股价上涨11.3%至8.83美元,此前该公司成功完成5000万美元融资

** 这家生物制药公司表示,已同意 (link) 以每股7.93美元的价格,通过私募方式向机构投资者出售约630万股股票及预先融资认股权证

** RNA公司股价周三收跌0.8%,报7.93美元,过去一个月累计跌幅约44%

** 公司计划将募集资金净额用于其两款主力候选产品的研发、其他研究项目等用途

** 公司预计,此次募集资金连同现有现金和投资,将足以支撑其运营至2028年

** Leerink担任此次配售的主承销商,Cantor Fitzgerald、巴克莱和富国银行共同参与

** 总部位于加利福尼亚州圣地亚哥的Atrium公司已与百时美施贵宝 BMY.N 和礼来 LLY.N 签署合作协议,其流通股约为1710万股

** Atrium 于2月27日开始公开交易 (link),此前该公司从 Avidity Biosciences (link) 剥离出来,而 Avidity Biosciences 已被瑞士制药商诺华(Novartis)收购 NOVN.S

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10